Author:
Iwazaki Shigeru,Takeyoshi Izumi,Ohwada Susumu,Sunose Yutaka,Aiba Masaaki,Tsutsumi Hirofumi,Kawashima Yoshiyuki,Matsumoto Koshi,Morishita Yasuo
Subject
Cardiology and Cardiovascular Medicine
Reference23 articles.
1. Braquet P, Touqui L, Shen TY, Vargaftig BB (1987) Perspectives in platelet-activating factor research. Pharmacol Rev 39:97–145.
2. Chang SW, Feddersen CO, Henson PM, Voelkel NF (1987) Plateletactivating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 79:1498–1509.
3. Doebber TW, Wu MS, Robbins JC, Choy BM, Chang MN, Shen TY (1985) Platelet-activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem Biophys Res Commun 127:799–808.
4. Qayumi AK, English JC, Feely EJE, Poostizadeh A, Nikbakht-Sangari M (1997) A new platelet-activating factor antagonist (CV-6209) in preservation of heart and lung for transplantation. Cardiovasc Drugs Ther 11:777–785.
5. Qayumi AK, English JE, Duncan S, Ansley DM, Pearson B, Nikbakht-Sangari M, Sammartino C, Fradet G. (1997) Extended lung preservation with platelet-activating factor-antagonist TCV-309 in combination with prostaglandin E1. J Heart Lung Transplant 16:946–955.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献